New cancer clinical trial: Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Published on: December 27, 2017 at 10:00AM
Condition:   Pancreatic Adenocarcinoma
Interventions:   Procedure: Fluorescence Imaging;   Other: Laboratory Biomarker Analysis;   Biological: Panitumumab;   Drug: Panitumumab-IRDye800;   Other: Pharmacological Study
Sponsors:   Eben Rosenthal;   National Cancer Institute (NCI)
Not yet recruiting
http://ift.tt/2ljs8yQ